A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

بواسطة Strati, Paolo, Nastoupil, Loretta J., Davis, Richard E, Fayad, Luis E., Fowler, Nathan, Hagemeister, Fredrick B., Kwak, Larry, Oki, Yasuhiro, Wang, Michael, Westin, Jason, Ruben, Charnelle E., Wesson, Emily T., Piekarz, Richard, Fanale, Michelle A., Lee, Hun Ju
الحاوية / القاعدة Haematologica (2020)

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

بواسطة Strati, Paolo, Chihara, Dai, Oki, Yasuhiro, Fayad, Luis E, Fowler, Nathan, Nastoupil, Loretta, Romaguera, Jorge E, Samaniego, Felipe, Garg, Naveen, Feng, Lei, Wesson, Emily T., Ruben, Charnelle E., Stafford, Mildred D., Nieto, Yago, Khouri, Issa F, Hosing, Chitra, Horowitz, Sandra B., Kamble, Rammurti T-., Fanale, Michelle A.
الحاوية / القاعدة Haematologica (2018)